[1]丁家安,倪管崟,印 于,等.选择性动脉栓塞术治疗肾血管平滑肌脂肪瘤的研究进展[J].介入放射学杂志,2024,33(05):560-564.
　DING Jiaan,NI Guanyin,YIN Yu,et al.Research progress in selective arterial embolization for renal angiomyolipoma[J].journal interventional radiology,2024,33(05):560-564.

点击复制

选择性动脉栓塞术治疗肾血管平滑肌脂肪瘤的研究进展()

PDF下载中关闭

• 
• 
• 

分享到：

参考文献/References:

［1］ Bissler JJ， Kingswood JC. Renal angiomyolipomata［J］. Kidney Int， 2004， 66： 924- 934.
［2］ Kiefer RM， Stavropoulos SW. The role of interventional radiology techniques in the management of renal angiomyolipomas［J］. Curr Urol Rep， 2017， 18： 36.
［3］ Vos N，Oyen R. Renal angiomyolipoma： the good， the bad， and the ugly［J］. J Belg Soc Radiol， 2018， 102： 41.
［4］ Lee KH，Tsai HY，Kao YT，et al. Clinical behavior and management of three types of renal angiomyolipomas［J］. J Formos Med Assoc， 2019， 118： 162- 169.
［5］ Kim JW，Kim JY，Ahn ST，et al. Spontaneous perirenal hemorrhage（Wunderlich syndrome）： an analysis of 28 cases［J］. Am J Emerg Med， 2019， 37： 45- 47.
［6］ Restrepo JCA，Millan DAC，Sabogal CAR，et al. New trends and evidence for the management of renal angiomyolipoma： a compre- hensive narrative review of the literature［J］. J Kidney Cancer VHL， 2022， 9： 33- 41.
［7］ Nelson CP， Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma［J］. J Urol， 2002， 168： 1315- 1325.
［8］ Fernandez- Pello S，Hora M，Kuusk T，et al. Management of sporadic renal angiomyolipomas： a systematic review of available evidence to guide recommendations from the European association of urology renal cell carcinoma guidelines panel［J］. Eur Urol Oncol， 2020， 3： 57- 72.
［9］ Marin， Davis D， Roy Choudhury- K， et al. Characterization of small focal renal lesions： diagnostic accuracy with single- phase contrast- enhanced dual- energy CT with material attenuation analysis compared with conventional attenuation measurements［J］. Radiology， 2017， 284： 737- 747.
［10］ 刁夏尧，吴少旭，孔坚秋，等． CT在肾错构瘤与肾细胞癌鉴别诊断中的应用及进展［J］． 中国肿瘤， 2020， 29：452- 457．
［11］ Jian L， Liu Y， Xie Y， et al. MRI- based radiomics and urine creatinine for the differentiation of renal angiomyolipoma with minimal fat from renal cell carcinoma： a preliminary study［J］. Front Oncol， 2022，12： 12876664.
［12］ Lobo JM，Clements MB，Bitner DP，et al. Does renal mass biopsy influence multidisciplinary treatment recommendations?［J］. Scand J Urol， 2020， 54： 27- 32.
［13］ Marconi L，Dabestani S，Lam TB，et al. Systematic review and meta- analysis of diagnostic accuracy of percutaneous renal tumour biopsy［J］. Eur Urol， 2016， 69： 660- 673.
［14］ Guo Y，Kapoor A，Cheon P，et al. Canadian urological association best practice report： diagnosis and management of sporadic angiomyolipomas［J］. Can Urol Assoc J， 2020， 14： E527- E536.
［15］ Yamakado K，Tanaka N，Nakagawa T，et al. Renal angiomyolipoma： relationships between tumor size，aneurysm formation，and rupture［J］. Radiology， 2002， 225： 78- 82.
［16］ Hatano T，Egawa S. Renal angiomyolipoma with tuberous sclerosis complex： how it differs from sporadic angiomyolipoma in both management and care［J］. Asian J Surg， 2020， 43：967- 972.
［17］ Qin C，Wang Y，Li P，et al. Super- selective artery embolization before laparoscopic partial nephrectomy in treating renal angiomyolipoma［J］. Urol Int， 2017， 99： 277- 282.
［18］ Zhang S， Lin T， Liu G， et al. Comparisons of the safety and effectiveness of robot- assisted versus laparoscopic partial nephrectomy for large angiomyolipomas： a propensity score- matched analysis［J］. Int Urol Nephrol， 2020， 52： 1675- 1682.
［19］ Jung Y， Choi MJ， Kim BM， et al. Transarterial embolization for sporadic renal angiomyolipoma： patient selection and technical considerations for optimal therapeutic outcomes［J］. Taehan Yongsang Uihakhoe Chi， 2022， 83： 559- 581.
［20］ Gong M，Liu Z，Su H，et al. Urgent transcatheter arterial embolization for wunderlich syndrome with hypovolemic shock secondary to ruptured renal angiomyolipoma［J］. Front Surg， 2021， 8：704478.
［21］ Preece P， Mees B， Norris B， et al. Surgical management of haemorrhaging renal angiomyolipoma in pregnancy［J］. Int J Surg Case Rep， 2015， 7C：89- 92.
［22］ Murray TE， Lee MJ. Are we overtreating renal angiomyolipoma： a review of the literature and assessment of contemporary management and follow- up strategies［J］. Cardiovasc Intervent Radiol， 2018， 41： 525- 536.
［23］ Lin L， Li X， Guan H， et al. Renal function， complications， and outcomes of a reduction in tumor size after transarterial embolization for renal angiomyolipomas： a meta- analysis［J］. J Int Med Res， 2019， 47： 1417- 1428.
［24］ Hocquelet A， Cornelis F， Le Bras Y， et al. Long- term results of preventive embolization of renal angiomyolipomas： evaluation of predictive factors of volume decrease［J］. Eur Radiol， 2014， 24： 1785- 1793.
［25］ Bardin F，Chevallier O，Bertaut A，et al. Selective arterial embo-lization of symptomatic and asymptomatic renal angiomyolipomas： a retrospective study of safety，outcomes and tumor size reduction［J］. Quant Imaging Med Surg， 2017， 7： 8- 23.
［26］ Razik A，Das CJ，Sharma S. Angiomyolipoma of the kidneys： current perspectives and challenges in diagnostic imaging and image- guided therapy［J］. Curr Probl Diagn Radiol， 2019， 48： 251- 261.
［27］ Villalta JD， Sorensen MD， Durack JC， et al. Selective arterial embolization of angiomyolipomas： a comparison of smaller and larger embolic agents［J］. J Urol， 2011， 186： 921- 927.
［28］ Sanampudi S， Raissi D. Optimal ethanol- ethiodol emulsion ratio in renal angiomyolipoma embolization： aquestion that remains unanswered［J］. J Clin Imaging Sci， 2019，9： 916.
［29］ Lee S， Park HS， Hyun D， et al. Radiologic and clinical results of transarterial ethanol embolization for renal angiomyolipoma［J］. Eur Radiol， 2021， 31： 6568- 6577.
［30］ Chick CM， Tan BS， Cheng C， et al. Long- term follow- up of the treatment of renal angiomyolipomas after selective arterial embolization with alcohol［J］. BJU Int， 2010， 105： 390- 394.
［31］ Rosenov A， Schindewolf M， Baumgartner I， et al. Selective arterial embolizations of renal angiomyolipomas using 96% ethanol： a case series of 5 patients［J］. Clin Med Insights Case Rep， 2020， 13：1179547620906863.
［32］ Claesen E， Bonne L， Laenen A， et al. Safety， efficacy， and predictors for late reintervention after embolization of renal angiomyolipomas - embolization renal angiomyolipoma［J］. Rofo， 2023， 195： 319- 325.
［33］ Urbano J， Paul L， Cabrera M， et al. Elective and emergency renal angiomyolipoma embolization with ethylene vinyl alcohol copolymer： feasibility and initial experience［J］. J Vasc Interv Radiol， 2017， 28： 832- 839.
［34］ Prigent FV，Guillen K，Comby PO，et al. Selective arterial embo-lization of renal angiomyolipomas with a N- butyl cyanoacrylate- lipiodol mixture： efficacy， safety， short- and mid- term outcomes［J］. J Clin Med， 2021， 10：4062.
［35］ Wang MQ， Duan F， Zhang H， et al. Comparison of polyvinyl alcohol versus combination of lipiodol- bleomycin emulsion and NBCA-lipiodol emulsion for renal angiomyolipoma embolization： a prospective randomized study［J］. AJR Am J Roentgenol， 2023， 220： 873- 883.
［36］ 刘 琦，侯毅斌，汤日杰，等． 选择性肾亚段动脉栓塞治疗肾错构瘤［J］． 介入放射学杂志， 2018， 27：477- 480．
［37］ Hongyo H，Higashihara H，Osuga K，et al. Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas： identi- fying predictors of 50% volume reduction［J］. CVIR Endovascular， 2020， 3： 84.
［38］ Tsuchiya S， Saiga A， Yokota H， et al. Prophylactic steroids for preventing postembolization syndrome after transcatheter arterial embolization of renal angiomyolipoma： a comparative study［J］. Interv Radiol（Higashimatsuyama）， 2023， 8： 1- 6.
［39］ Alzen G，Basedow J，Luedemann M，et al. Partial splenic embo-lization as an alternative to splenectomy in hypersplenism： single center experience in 16 years［J］. Klin Padiatr， 2010， 222： 368- 373.
［40］ Duan XH， Zhang MF， Ren JZ， et al. Urgent transcatheter arterial embolization for the treatment of ruptured renal angiomyolipoma with spontaneous hemorrhage［J］. Acta radiol， 2016， 57： 1360- 1365.